AGRANA Beteiligungs-AG RCB Investors Conference in Zürs (April 9-10, 2008) Adding value to nature s gifts.
|
|
- Logan Armstrong
- 5 years ago
- Views:
Transcription
1 AGRANA Beteiligungs-AG RCB Investrs Cnference in Zürs (April 9-10, 2008) April 9,
2 AGRANA at a glance AGRANA prducts yu meet everyday Sugar Sugar is sld - t cnsumers via the fd trade (20%) and - t manufacturers: e.g. sft drinks industry, cnfectinery industry, fermentatin industry, ther fd and beverage industries (80%). April 9, Starch AGRANA prduces starch and special starch prducts. Starch is a cmplex carbhydrate which is insluble in water. Starch is used in fd prcessing e.g. as thickener and fr technical purpses e.g. in the paper manufacturing prcess. Biethanl is part f ur starch business. Fruit Fruit juice cncentrates custmers are fruit juice and beverage bttlers and fillers (20%). Fruit preparatins are special custmized prducts (80%) fr - the dairy industry, - the baked prducts industry, -the ice-cream industry.
3 AGRANA Key figures Revenues Staff Prcessed raw material Revenues e SUGAR Leading prducer f sugar in Central and Eastern Eurpe 805 m 2,723 4,700,000 tns f sugar beets and 180,000 tns f raw sugar ~ 750 m STARCH One f Eurpe s leading suppliers f specialty prducts and isglucse 253 m ,000 tns f starch ptates and 820,000 tns f crn ~ 300 m FRUIT Wrld s leader in fruit preparatins and Eurpe s fremst manufacturer f fruit juice cncentrates Cnslidatin TOTAL 915 m 4,724 (57 m ) 1,916 m 8, ,000 tns f fruits 6,830,000 tns ~ 850 m ~ 1,900 m April 9,
4 AGRANA's Strategy Grwth in AGRANA's cre businesses SUGAR Strengthening the grup's leadership in Central Eurpe and fcus n a strng market psitin in the Balkan cuntries AGRANA aims t maintain its psitin as an efficiency and technlgy leader in the Central Eurpean sugar industry STARCH FRUIT April 9, Pursuing the strategy f increasing the utput f highly refined speciality starch prducts Fcus n the prductin f innvative custmer-rientated prducts and starch based slutins fr the custmers Enlargement f crn starch capacities as well as isglucse and biethanl prductin Full supply f the Austrian biethanl market and leading rle in CEEC AGRANA is aiming t cntinue faster-than-market grwth in fruit preparatins and fruit juice cncentrates Fruit Preparatins: further expansin arund the glbe, enabling AGRANA t service its glbal fd industry custmers Fruit Juice Cncentrates: further expansin beynd Eurpe Strng rganic grwth but als acquisitins under review
5 Cnsistent Grwth Strategy Develpment f prductin facilities within the last six years Segment Sugar Starch Fruit TOTAL 1 as f Feb. 29, Sugar factry Starch factry Fruit factry April 9,
6 Revenues t e AGRANA shws significantly strnger than market grwth in all its business segments. ~1,900.0 in m CAGR +13.5% p.a. 1, , April 9, e incl. 14 m Fruit
7 EBIT t e Steady grwth f prfitability within the last years. Prfit increased clearly ver revenues grwth. in m CAGR +14.5% p.a April 9, e incl. 14 m Fruit
8 AGRANA s Sharehlder Structure Shares utstanding: 14,202,040 Market capitalizatin (as f Feb. 29, 2008): ~ 1,024 m ~ 10.5% Raiffeisen Bank Cp. Lwer Austria ZBG Südzucker ~ 80% ~ 50% ~ 50% Free Flat Z & S Zucker und Stärke Hlding AG 24.5% 75.5% April 9,
9 Milestnes f current fiscal year May May September September Nvember Nvember December February April 9, AGRANA starts up new fruit preparatins plant in Cabreuva, Brazil 10 Years Anniversary f AGRANA Fruit Ukraine AGRANA starts trial peratin f the new biethanl plant in Pischelsdrf n schedule, Cmmdity bm requires pstpnement f start f prductin until spring 2008 AGRANA expects acceleratin f EU sugar regime refrm due t new incentives fr beet farmers and sugar industry fr renuncing quta AGRANA pens first-f-its-kind bigas plant in Kapsvár, Hungary Hungary t return 50% f its sugar quta t the restructuring fund - AGRANA cncentrates its sugar prductin at ne refinery AGRANA Fruit pens Innvatin and Prduct Develpment Center in Cleveland, USA Refrm f EU Sugar Regime prgresses Permanent reductin f additinal 2.6 mill. tnnes sugar quta was annunced in the perid t 31 January 2008 Nrdzucker quits sugar prductin in Hungary AGRANA is the sle sugar prducer in Hungary
10 SUGAR. AGRANA is the leading prducer f sugar in Central and Eastern Eurpe (CEE). April 9,
11 EU Sugar Regime The PAST: WTO panel decisin cuts sugar exprts Reductin f 2.2 millin tns sugar quta fr sugar marketing year int restructuring fund, substantially less than expected On Sept. 26, 2007 the EU-Cuncil has adpted the refrm f the sugar regime refrm The PRESENT: AGRANA expects acceleratin f the refrm prcess due t further 2.6 millin tnnes f permanent renunciatins until Jan. 31, 2008 AGRANA renunced quta f 13.5 % in Austria, 23 % in Slvakia, 30 % in Hungary (-> clsure f sugar plant in Petöhaza) in the first and secnd wave N preventive withdrawal fr sugar marketing year THE FUTURE: Only anther 0.4 millin tnnes will be needed t meet the refrm target f 6 millin tnnes f quta reductins by 2010 by a final cut f the EU-sugar quta fr all EU cuntries in sugar marketing year withut cmpensatin April 9, C-sugar The Future f EU Sugar Regime 20 millin tnnes EU sugar quta 1.6 1, ACP -2.6 Fllwing a WTO panel decisin, C-sugar exprts are n lnger permitted. WTO limits (current exprt qutas) LDC and Western Balkan Agreement
12 STARCH. AGRANA is a well psitined starch specialist in Eurpe. April 9,
13 Cntrast: Bidiesel and Biethanl Palm seed Rapeseed Sybean Wheat Crn Sugar beet juice Bidiesel Biethanl Added t DIESEL Added t PETROL April 9,
14 Price Develpment f Cereals Pstpnement f Biethanl peratin in Pischelsdrf Austria CORN Qutatin (MATIF) Histrical price peak because f reginal lw crps, high physical demand and speculatins n a glbal basis /tn Beginning f Octber price develpment recvered slightly WHEAT Qutatin (MATIF) Wheat prices dubled since the beginning f /tn Speculatins n internatinal cmmdity exchanges peak ff Ablitin f the EU s 10% set-aside scheme shuld lead t an increase in grain acreage and prductin in Eurpe in 2008 => additinal 4-6 % f EU s acreage fr grain prductin expected 2007: apprx. 1.5 % f ttal EU grain prductin was used fr ethanl prductin April 9,
15 Biethanl Activity by AGRANA Status Pischelsdrf Full capacity prductin start: end f May 2008 Cverage f raw material until new crp AGRANA expects realistic raw material price levels ( 200 /t) due t: Ablitin f 10 % set-aside scheme within EU in 2008 Higher prices mtivate farmers t intensify cultivatin f cereals Nrmal crp in CEECs Cntracts with OMV were cmpletely fulfilled via deliveries frm ther grup cmpanies Ethanl prices culd recver because f increasing sugar price and high dmestic Ethanl cnsumptin in Brazil April 9,
16 FRUIT. AGRANA is wrld s leading supplier f fruit preparatins and fruit juice cncentrates. April 9,
17 FRUIT Segment Business Mdel Fruit Preparatins Based n mstly frzen fruits tailr-made custmer prducts (several thusand receipts wrldwide) shelf life f the fruit preparatin: apprx. 6 weeks -> necessity t prduce reginal Fruit Juice Cncentrates Prductin f fruit juice cncentrates frm fresh fruits in the grwing area f the fruits (water cntent and quality f the fruits dn't allw far transprts) shelf life f fruit juice cncentrates: apprx. 2 years can be shipped arund the wrld April 9,
18 FRUIT Segment Market psitin Fruit Preparatins High market grwth in Russia, USA, Mexic, Brazil, China. Additinal prductin sites t meet grwing needs f new custmers Market entry in regins with high grwth ptential where AGRANA custmers are already perating (Yghurt prducers) Fruit Juice Cncentrates Further grwth in existing markets Increase in market share via distributin channel enhancement in the EU and Russia current prductin plants grwth area April 9,
19 FRUIT Segment Key Cnsumer Trends Glbal CAGR f: 5,0% Cntinuus grwth in Fruit Preps & Fruit Juice until Main grwth cntributrs in Fruit are expected t be China, Russia, Eastern Eurpe and the Americas tnnes Key Cnsumer Trends Wellness, Vitality & Fitness f 2010f Yghurt and Chilled Desserts Glbal CAGR f: 6,0% Surce: Leatherhead 2005 and 2007, Glbal Fd Markets, Intern. Overview Cnvenience 70,0 60,0 49,5 52,7 62,2 Pleasure, New Taste, Refreshing Functinality cmbined with psitive effect n immune system bn litres 50,0 40,0 30,0 20,0 43,1 45,4 10,0 0, f 2010f Fruit Juices & Drinks Surce: Leatherhead 2005 and 2007, Glbal Fd Markets, Intern. Overview April 9,
20 Outlk April 9,
21 Outlk fr Financial Year Grup Revenue Frecast : ~ 1.9 bn Key factrs: - Sugar: lwer quantities t market (EU Sugar Regime) - Starch: rganic grwth > 10%, price increases cmpensate raw material price increases - Fruit: financial perid f 12 instead f 14 mnths, rganic grwth and price increases due t higher raw material csts SUGAR: Lwer sugar revenues due t reduced sugar qutas Efficiency imprvements in prductin and marketing Out f Quta-Beet-Cntracts fr the chemical industry STARCH: Gd perfrmance despite extrardinary high crn price increase Over-Cmpensatin f lwer than expected biethanl revenues FRUIT: Organic grwth especially in CEECs, Asia and the Americas Strengthening f earnings by utilisatin f synergies April 9,
22 Outlk SUGAR Segment Cnslidatin in CEECs Brčk plant start-up Strng market psitin in the Balkan regin STARCH Segment Grup Revenues Frecast > 2,100 m 1,916 m (1) ~ 1,900 m 1,500 m ~47% ~48% 48% Grwing revenues due t capacity increases and specialisatin strategy % 14% 11% ~14% ~20% Biethanl prvides additinal grwth FRUIT Segment % 41% ~38% ~33% Strng rganic grwth Further acquisitins r green field peratins e e Sugar Starch Fruit (1) Revenues include 14 mnths fr fruit cmpanies April 9,
23 Market Develpments in SUGAR Segment Increase f Wrld Market Prices expected Market recvery as a cnsequence f EU sugar market refrm end f 2008 at the earliest STARCH Segment Cntinuus market grwth fr starch prducts in emerging markets Specialisatin strategy will safeguard better prduct mix and attractive margins Prfitable biethanl prductin requires either an increase in ethanlprices r/and lwer raw material prices FRUIT Segment Cntinuus grwth wrld wide Average glbal grwth rate f 5 % (Fruit) resp. 6 % (Juice) until 2010 Nrmalisatin f crp situatins and price levels f raw materials April 9,
24 Planned activities in SUGAR Segment Cmpletin f the restructuring prgram Investment fcus: imprvement f energy efficiency Start up Brck refinery STARCH Segment Full capacity f biethanl activities Full 3,000 tns daily grind at Hungrana FRUIT Segment Expansin prjects in grwing regins, esp. Mscw April 9,
25 Disclaimer This presentatin is being prvided t yu slely fr yur infrmatin and may nt be reprduced r further distributed t any ther persn r published, in whle r in part, fr any purpse. This presentatin cmprises the written materials/slides fr a presentatin cncerning AGRANA Beteiligungs-Aktiengesellschaft ( Cmpany ) and its business. This presentatin des nt cnstitute r frm part f any ffer r invitatin t sell r issue, r any slicitatin f any ffer t purchase r subscribe fr, any shares in the Cmpany, nr shall it r any part f it frm the basis f, r be relied n in cnnectin with, any cntract r investment decisin. This presentatin includes frward-lking statements, i.e. statements that are nt histrical facts, including statements abut the Cmpany's beliefs and expectatins and the Cmpany's targets fr future perfrmance are frward-lking statements. These statements are based n current plans, estimates and prjectins, and therefre investrs shuld nt place undue reliance n them. Frward-lking statements speak nly as f the date they are made, and the Cmpany undertakes n bligatin t update publicly any f them in light f new infrmatin r future events. Althugh care has been taken t ensure that the facts stated in the presentatin are accurate, and that the pinins expressed are fair and reasnable, the cntents f this presentatin have nt been verified by the Cmpany n representatin r warranty, express r implied, is given by r n behalf f the Cmpany any f its respective directrs, r any ther persn as t the accuracy r cmpleteness f the infrmatin r pinins cntained in this presentatin. Neither the Cmpany nr any f its respective members, directrs, fficers r emplyees r any ther persn accepts any liability whatsever fr any lss hwsever arising frm any use f this presentatin r its cntents r therwise arising in cnnectin therewith. April 9,
Press Release. Adocia: Activity and results for the first half of 2013
Press Release Adcia: Activity and results fr the first half f 2013 Intensificatin f R&D activity ahead f the launch f three clinical trials fr insulin prjects, starting in the secnd half f 2013 Net result
More informationPress Release. Adocia Reports Operational and Financial Results for the First Half of 2014
Press Release Adcia Reprts Operatinal and Financial Results fr the First Half f 2014 Majr clinical results reprted n tw frmulatins based n insulin Sund financial psitin with apprximately EUR 16 millin
More informationVirus Filtration Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Virus Filtratin Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal assisted walking device market is expected t reach ver USD 2.0 billin by 2024 accrding
More informationIntracranial Pressure (ICP) Monitoring Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Intracranial Pressure (ICP) Mnitring Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal intracranial pressure mnitring devices market is expected t
More informationPancreatic Cancer Treatment Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The rising prevalence f besity, alchl cnsumptin, and smking is expected t prpel
More informationTrauma Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Trauma Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal trauma devices market size was valued at arund USD 6.9 billin in 2017 and is anticipated
More informationTechnology to overcome challanges
Technlgy t vercme challanges MORE THAN 25 YEARS DEVELOPING SOLUTIONS Przyn is a cmpany specialized in enzymes slutins and biingredients applicatins, ver 25 years f experience in develping bitechnlgy slutins.
More informationIntravascular Catheters Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Intravascular Catheters Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal intravascular catheters market size was valued at USD 4.1 billin in 2018
More informationElectrosurgical Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Electrsurgical Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc Grwing awareness regarding mst recent surgical techniques in develping regins is expected
More informationPhotomedicine Devices And Technologies Market Size, Share & Trends Analysis Report and Segment Forecast, 2024 Grand View Research, Inc
Phtmedicine Devices And Technlgies Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2024 Grand View Research, Inc The glbal phtmedicine devices and technlgies market accunted fr USD 314.9
More informationSecond Quarter 2009 Results. Analyst and Media Conference July 28, 2009 Zurich
Secnd Quarter 2009 Results Analyst and Media Cnference July 28, 2009 Zurich This presentatin cntains frward lking statements which invlve risks and uncertainties. The actual perfrmance, results and timing
More informationAngiography Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Angigraphy Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal angigraphy devices market size was valued at USD 9.8 billin in 2018 and is prjected
More informationGoldman Sachs Dynamo Strategy Index
INDEX INFORMATION Ticker GSDYNMO5 RIC.GSDYNMO5 Thmsn Identifier Index Spnsr Gldman, Sachs & C. Currency USD Number f Underliers max. 8 Vlatility Target 5% Daily Vlatility Cntrl 5.50% Index Calculatr Slactive
More informationSports Nutrition Industry Across Different Regional Markets
Sprts Nutritin Industry Acrss Different Reginal Markets Supplements, the gd, the bad & the ugly China Internatinal Sprts Nutritin Industry Summit 2017 September 6 th, 2017 Mr. Jack Sehgal Directr, Business
More informationInvestor Update November 2011
Investr Update Nvember 2011 Cmpany Strategy Prject Style Cnventinal High Impact Prjects (ie big prspects: high IP s and large well reserves). Strng 3D prspects with gd analgues prspects are selected based
More informationEndodontic Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Enddntic Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal enddntic devices market size was valued at USD 1.56 billin in 2018 and is expected
More informationThe Shea Supply Chain and its Value in Confectionery Products. GSA New York May 2014
The Shea Supply Chain and its Value in Cnfectinery Prducts. GSA New Yrk May 2014 IOI Lders Crklaan is part f IOI Grup Prperty develpment Oil palm plantatins Olechemicals Edible Oils (including IOI Lders
More informationAmniotic Membrane Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Amnitic Membrane Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal amnitic membrane market size was valued at USD 2.26 billin in 2017 and is estimated
More informationENT Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2022 Grand View Research, Inc
ENT Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2022 Grand View Research, Inc The glbal ENT devices market size was valued at USD 17.2 billin in 2016. It is estimated t prgress
More informationFOUNDATIONS OF DECISION-MAKING...
Table f Cntents FOUNDATIONS OF DECISION-MAKING... Errr! Bkmark nt Describe the decisin-making prcess pp.62-66... Errr! Bkmark nt Explain the three appraches managers can use t make decisins pp.67-70 Errr!
More informationThe Cannabis Act and Regulations
The and Regulatins OVERVIEW The and Regulatins cme int frce n Octber 17, 2018 and replaces the Access t Cannabis fr Medical Purpses Regulatins (ACMPR), and any mentin f Cannabis and Marihuana in the Narctics
More informationRetinal Surgery Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Retinal Surgery Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal retinal surgery devices market size was estimated at USD 1.56 billin in 2016
More informationOxford Immunotec Company Overview
Oxfrd Immuntec Cmpany Overview J.P. Mrgan Healthcare Cnference 2019 Oxfrd Immuntec Glbal PLC 94C Innvatin Drive Miltn Park, Abingdn Oxfrdshire, OX14 4RZ, United Kingdm Cmpany Number 08654254 www.xfrdimmuntec.cm
More informationSession 5: Is FOOD fair?
Sessin 5: Is FOOD fair? Age range: 7-11 years Outline Learners will play a simulatin game Can yu beat the system?, t develp their understanding f the glbal fd system and its winners and lsers. They will
More informationOrganizational Capacity for Change and Patient Safety
Organizatinal Capacity fr Change and Patient Safety Debrah M. Nadzam, PhD, FAAN - Jint Cmmissin Resurces Lrrie Jnes-Hartley, MSN, CRRN-A - Durham Reginal Hspital Presentatin Objectives Briefly describe
More informationINTERIM REPORT JANUARY SEPTEMBER 2017
INTERIM REPORT JANUARY SEPTEMBER 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN Octber 27, 2017 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap):
More informationD E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y
D E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y 2 A B O U T This dcument prvides a summary f key findings fr the Derby, Derbyshire, Nttingham and
More informationDigital Patient Monitoring Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Digital Patient Mnitring Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal digital patient mnitring devices market size was valued at USD 38
More informationCode of employment practice on infant feeding
Cde f emplyment practice n infant feeding An Emplyer s guide t: Sectin 69Y f the Emplyment Relatins Act 2000 Frewrd As Minister f Labur, I am pleased t publish the Cde f Emplyment Practice n Infant Feeding.
More informationFood information to consumers - Commission proposal - COM (2008) 40 final 2008/0028 (COD) The European Heart Network s position in a nutshell
Fd infrmatin t cnsumers - Cmmissin prpsal - COM (2008) 40 final 2008/0028 (COD) The Eurpean Heart Netwrk s psitin in a nutshell Summary On 30 January 2008 the Eurpean Cmmissin published its prpsal fr a
More informationJapanese Rice Producers' Shift from High Yield to High Palatability and Quality -Characteristics of Highly Palatable Rice-
Jurnal f Develpments in Sustainable Agriculture 5: 96-1 (21) Japanese Rice Prducers' Shift frm High Yield t High Palatability and Quality -Characteristics f Highly Palatable Rice- Yuji Nitta* Cllege f
More informationAppendix C. Master of Public Health. Practicum Guidelines
Appendix C Master f Public Health Practicum Guidelines 0 Gergia State University, Schl f Public Health Master f Public Health Practicum Guidelines Fr mre infrmatin, cntact Jessica Hwell Pratt, MPH Practicum
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More informationA Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013
A Unified Apprach t Cnflict Mineral Cmpliance fr the Tungsten Industry The Westin, Sydney, 23 September 2013 Backgrund Cmpliance f public US dwnstream tungsten users with the reprting requirements f the
More informationREPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE
REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN February 12, 2018 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap): XVIVO HIGHLIGHTS
More informationTELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT
TELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT Intrductin This is the Explanatry Statement fr the revised Cmmunicatins Alliance Telecmmunicatins Cnsumer Prtectins (TCP) Industry
More informationFRUIT STARCH SUGAR. AGRANA Beteiligungs-AG. The natural upgrade. Corporate presentation
FRUIT STARCH SUGAR The natural upgrade AGRANA Beteiligungs-AG Corporate presentation 2018 1 ABOUT US AGRANA FACTS We refine agricultural raw materials, turning them into a range of different industrial
More informationTranscatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Transcatheter Emblizatin And Occlusin Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal Transcatheter Emblizatin and Occlusin (TEO) devices
More informationWCPT awards programme 2015
WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.
More informationLEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST
OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED
More informationCancer Association of South Africa (CANSA)
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.
More informationUNIT 2: mapping bananas
Oxfam Educatin www.xfam.rg.uk/educatin UNIT 2: mapping bananas Age range: 7-11 years Outline Learners will investigate sme f the cuntries where the bananas we eat in the UK are grwn. They will first lcate
More informationRugby Nutrition: Achieving Body Composition Goals Practice Tips
www.bksmart.cm /BkSmart @BkSmart Rugby Nutritin: Achieving Bdy Cmpsitin Gals Practice Tips Whether yu need t increase r maintain high levels f muscle mass fr strength and pwer, and/r if yu need t lse r
More informationCall for evidence on the use of skin sensitisers, skin irritants and corrosive substances in textile and leather articles, hides and furs
Call fr evidence n the use f skin sensitisers, skin irritants and crrsive substances in textile and leather articles, hides and furs Backgrund dcument Backgrund Prductin and prcessing f textile and leather
More informationDHMO Provider Choice Product Exit, 2-50 and 51+
Date: April 27, 2018 Market: Dental, 2-50 and 51+ DHMO Prvider Chice Prduct Exit, 2-50 and 51+ Maryland and Virginia Only Beginning with July 2018 renewals, DHMO Prvider Chice (PC) plans will be discntinued
More informationFrontier School of Innovation District Wellness Policy
Frntier Schl f Innvatin 6700 Crprate dr. Suite 150 Phne: 816-363-1907 http://www.kcfsi.rg/ Frntier Schl f Innvatin District Wellness Plicy The Bard prmtes healthy schls, by supprting wellness, gd nutritin,
More informationMalaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee
Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and
More informationSUMMARY THE EUROPEAN COMMUNITY STRATEGY
SUMMARY THE EUROPEAN COMMUNITY STRATEGY FOR THE PHASEOUT OF CFCS IN MDIS 1. The Eurpean Cmmunity s transitin strategy fr the phaseut f CFCs in metered-dse inhalers (MDIs) was submitted t the Parties t
More informationARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST
ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST 7 th July 2017 Cntent 1 Intrductin 2 Tpics fr EOI in the 4 th call 3 The applicatin prcess and imprtant dates 4 Guideline fr EOIs Deadline
More informationA fake medicine that passes itself off as a real, authorised medicine. (1)
Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces
More informationRate Lock Policy. Contents
Rate Lck Plicy Cntents Rate Lcks... 2 Rate Lck Cnfirmatin... 2 Lck Term... 2 Pre-Lck... 2 Maximum Qualified Rate... 3 Extensins... 3 Cst t Extend... 3 Relcks... 4 Re-Negtiatin r Flat Dwn Plicy... 4 Prgram
More informationCatherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support
Catherine Wrthingham Fellws f APTA Instructins fr Writing a Letter f Supprt Fllwing is infrmatin designed t assist persns asked t write a letter f supprt fr a nminee fr the American Physical Therapy Assciatin
More informationPersistence Market Research
Ophthalmic Devices Market - Glbal Study n Ophthalmic Devices: Asia t Witness Highest Grwth by 2020 Persistence Market Research Glbal Ophthalmic Devices Market Will Reach $2,685.1 millin in 2020: Persistence
More informationCampus Climate Survey
Campus Climate Survey Executive Summary www.ecu.edu/ecyu 2016 A prject spnsred by the Office fr Equity and Diversity Executive Summary Prject Backgrund In FY 2013-2014, the Campus Climate Cmmissin prpsed
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:
More informationSTANDARD FOR POMEGRANATE (CODEX STAN )
CODEX STAN 310-2013 Page 1 f 5 1. DEFINITION OF PRODUCE STANDARD FOR POMEGRANATE (CODEX STAN 310-2013) This Standard applies t fruits f cmmercial varieties f pmegranates grwn frm Punica granatum L., f
More informationCatherine Worthingham Fellows of the APTA Instructions for Nominators
Catherine Wrthingham Fellws f the APTA Instructins fr Nminatrs The fllwing infrmatin was prepared t aid nminatrs in making a nminatin fr the APTA membership categry f Catherine Wrthingham Fellw. Please
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationClimate Change and The 12 Step Framework
Climate Change and The 12 Step Framewrk Is there a there there? Julie Hayes Nvember 13, 2012 Where n earth did this crazy idea cme frm? Climate Change and The 12 Step Framewrk Why? 3 What I learned n my
More informationneuropharmaceuticals commericalization
neur neurpharmaceuticals cmmericalizatin neurnan pharma 11th Annual NanBusiness Cnference Nanmanufacturing Summit September 4-6, 2012 Bstn, MA neur I. Intrductin 2 Alexander Kabanv, C-funder UNC - Chapel
More informationINTRODUCTION... 2 PD... 2 CRS... 2 PE... 2 DRAMA... 2 MFL... 2 ART... 3 COMPUTING & MULTIMEDIA... 3 SOCIOLOGY... 3 CHILD DEVELOPMENT...
CONTENTS INTRODUCTION... 2 PD... 2 CRS... 2 PE... 2 DRAMA... 2 MFL... 2 ART... 3 COMPUTING & MULTIMEDIA... 3 SOCIOLOGY... 3 CHILD DEVELOPMENT... 3 HISTORY... 3 GEOGRAPHY... 4 TEXTILES... 4 BUSINESS STUDIES...
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationStatement of Work for Linked Data Consulting Services
A. Backgrund Infrmatin Statement f Wrk fr Linked Data Cnsulting Services The Natinal Library f Medicine (NLM), in Bethesda, Maryland, is a part f the Natinal Institutes f Health, US Department f Health
More informationAction plan: serialisation of Nordic packages focus on Product Codes
19.6.2017, versin 5 Actin plan: serialisatin f Nrdic packages fcus n Prduct Cdes The aim f this dcument is t help pharma cmpanies t prepare fr prduct cde changes and t be able t maintain prduct cdes in
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationWALNUT KERNEL-HALVES (light color)
WALNUT KERNEL-HALVES (light clr) DESCRIPTION Prduct: rganic walnut kernels, separate int tw parts apprximately equal and intact, light clred T be cnsidered "half", 7/8 r mre f the kernel must be intact
More informationThe data refer to persons aged between 15 and 54.
Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing
More informationFad diets Ask the Dietitian Michele Lucas RD CDE
Fad diets Ask the Dietitian Michele Lucas RD CDE WHAT YOU SHOULD KNOW: Weighing t much is nt gd fr yur health. Being verweight increases yur risk f health prblems, like heart prblems, high bld pressure,
More information2016 CWA Political Action Fund Administrative Procedures Checklist
2016 CWA Plitical Actin Fund Administrative Prcedures Checklist 1. Dates f Prgram The 2016 CWA Plitical Actin Fund (federal plitical actin cmmittee- CWA-COPE PCC) Prgram will be cnducted n a calendar year
More informationModule 6: Goal Setting
Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals
More informationThe U.S. & The Global Fund to Fight AIDS, Tuberculosis and Malaria
The U.S. & The Glbal Fund t Fight AIDS, Tuberculsis and Malaria The Glbal Fund t Fight AIDS, Tuberculsis and Malaria (Glbal Fund) is an independent, multilateral, financing entity designed t raise significant
More informationPresident Chirac understood that fighting disease is not just health systems and hospitals, it is about people. We must place people at the centre.
Michel Sidibé Executive Directr, UNAIDS Speech Opening Ceremny 2016 Wrld Cancer Cngress 31 st Octber 2016, Paris, France Cngratulatins and grateful thanks t the rganizers - Unin fr Internatinal Cancer
More informationPreventing and Responding to Emerging IDs the role of WHO
Preventing and Respnding t Emerging IDs the rle f WHO Mark Jacbs Directr, Divisin f Cmmunicable Diseases WHO Respnding t Emerging Infectius Diseases Sympsium 21st Public Health Summer Schl University f
More informationACMPR - Access to Cannabis for Medical Purposes Regulations Part 1 Commercial Production
- Access t Cannabis fr Medical Purpses Regulatins Part 1 Cmmercial Prductin September 2017 OVERVIEW Yu must cmply with regulatins t supply medical cannabis as f August 24, 2016 There are fur parts t the
More informationCFS Private Sector modalities
CFS Private Sectr mdalities APPROVED September 8, 2011 A. BACKGROUND 1. Fd security exists when all peple at all times have physical and ecnmic access t sufficient, safe and nutritius fd t meet their dietary
More informationHerbal Medicines: Traditional Herbal Registration
Herbal Medicines: Traditinal Herbal Registratin In the UK, cmpanies can nly sell herbal medicines with the apprpriate prduct licence, as fllws: A full marketing authrisatin based n the safety, quality
More informationPalm Solutions for Replacing PHVO. 2014, Dr. Gerald McNeill
Palm Slutins fr Replacing PHVO 2014, Dr. Gerald McNeill Histry f Gd Fat and Bad Fat 1950s Prf. Ancel Keyes Fat is bad Especially Saturated Fat 1970s Phil Sklff The Pisning f America Saturated Fat is Pisn
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationYear 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:
Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:
More informationMGPR Training Courses Guide
MGPR Training Curses Guide fiscal cde 92107050921 1. Descriptin The training prgram supprted by MGPR is prpsed by a grup f excellent mentrs/educatrs, accmplished in Pesticides Management and Analysis,
More informationThe estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by
ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the
More informationCode of Conduct for Employees
Crprate Human Resurces Plicy Cntent Updated: 2016-06-22 Wrk Envirnment Plicy N: HR-01-09 Page 1 f 5 Apprval: 2014-09-24 Cde f Cnduct fr Emplyees POLICY STATEMENT The residents and businesses f the City
More informationJefferies 2014 Global Healthcare Conference. June 3, 2014
Jefferies 2014 Glbal Healthcare Cnference June 3, 2014 Frward Lking Statements This presentatin cntains certain frward lking statements relating t the cmpany s financial results, business prspects and
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationWorld Confederation for Physical Therapy Congress , May Singapore
Wrld Cnfederatin fr Physical Therapy Cngress 2015 1-4, May Singapre Call fr applicatins fr Chair f the Internatinal Scientific Cmmittee The Executive Cmmittee f WCPT invites applicatins and suggestins
More informationHSC 106 Personal Health Plan for Learning Activities & Assessment linked to Michigan Teacher Preparation Standards
HSC 106 Persnal Health Plan fr Learning Activities & Assessment linked t Michigan Teacher Preparatin Standards Standard 1 Cmpetency 1.1 Understand basic health cntent as it relates t schl health educatin.
More informationAll Foods Sold in Schools
All Fds Sld in Schls USDA s Smart Snacks in Schls Prpsal USDA recently prpsed practical, science-based nutritin standards fr snack fds and beverages sld t children at schl during the schl day. The prpsed
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationExtended G/L Segment Codes
Extended G/L Segment Cdes Cpy Segment Cdes t ther Sage 300 cmpanies Extended G/L Segment Cdes Extended G/L Segment Cdes is an enhanced replacement fr the Sage G/L Segment Cdes screen. It lets yu cpy segment
More informationReliability and Validity Plan 2017
Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,
More informationIMPROVING SPORTING ABILITY THROUGH VIRTUAL REALITY INTRODUCTION
IMPROVING SPORTING ABILITY THROUGH VIRTUAL REALITY INTRODUCTION S E C T I O N 0 1 Dear hckey parents, We prudly ffer t yur sn/daughter participatin in a unique athletic training prgram in Virtual Reality
More information"Hogging down crops" : cost of producing crops and pork
Luisiana State University LSU Digital Cmmns LSU Agricultural Experiment Statin Reprts LSU AgCenter 1923 "Hgging dwn crps" : cst f prducing crps and prk Albert Franklin Kidder Fllw this and additinal wrks
More informationEMC believes the information in this publication is accurate as of its publication date. The information is subject to change without notice.
EMC DATA PROTECTION ADVISOR (DPA) MIGRATION TECH NOTE With SQL as external database fr t 5.5.1 and later DPA versin 5.x releases t 6.0 SP1 and later ABSTRACT This Tech Nte prvides the steps t migrate frm
More informationIndependent Charitable Patient Assistance Program (IPAP) Code of Ethics
Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More information